Literature DB >> 27062895

Developmental expression of paraoxonase 2.

Jacqueline M Garrick1, Khoi Dao2, Rian de Laat2, John Elsworth3, Toby B Cole4, Judit Marsillach5, Clement E Furlong5, Lucio G Costa6.   

Abstract

Paraoxonase 2 (PON2) is a member of the paraoxonase gene family also comprising PON1 and PON3. PON2 functions as a lactonase and exhibits anti-bacterial as well as antioxidant properties. At the cellular level, PON2 localizes to the mitochondrial and endoplasmic reticulum membranes where it scavenges reactive oxygen species. PON2 is of particular interest as it is the only paraoxonase expressed in brain tissue and appears to play a critical role in mitigating oxidative stress in the brain. The aim of this study was to investigate the expression of PON2 at the protein and mRNA level in the brain and liver of mice through development to identify potential age windows of susceptibility to oxidative stress, as well as to compare expression of hepatic PON2 to expression of PON1 and PON3. Overall, PON2 expression in the brain was lower in neonatal mice and increased with age up to postnatal day (PND) 21, with a significant decrease observed at PND 30 and 60. In contrast, the liver showed continuously increasing levels of PON2 with age, similar to the patterns of PON1 and PON3. PON2 protein levels were also investigated in brain samples from non-human primates, with PON2 increasing with age up to the infant stage and decreasing at the juvenile stage, mirroring the results observed in the mouse brain. These variable expression levels of PON2 suggest that neonatal and young adult animals may be more susceptible to neurological insult by oxidants due to lower levels of PON2 in the brain. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Brain; Development; Liver; Oxidative stress; Paraoxonase 1; Paraoxonase 2; Paraoxonase 3

Mesh:

Substances:

Year:  2016        PMID: 27062895      PMCID: PMC5055469          DOI: 10.1016/j.cbi.2016.04.001

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  41 in total

1.  One enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity.

Authors:  Sebastian Altenhöfer; Ines Witte; John F Teiber; Petra Wilgenbus; Andrea Pautz; Huige Li; Andreas Daiber; Heidrun Witan; Albrecht M Clement; Ulrich Förstermann; Sven Horke
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?

Authors:  Gennaro Giordano; Toby B Cole; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-23       Impact factor: 4.219

3.  Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities.

Authors:  Dragomir I Draganov; John F Teiber; Audrey Speelman; Yoichi Osawa; Roger Sunahara; Bert N La Du
Journal:  J Lipid Res       Date:  2005-03-16       Impact factor: 5.922

4.  Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation.

Authors:  Sven Horke; Ines Witte; Petra Wilgenbus; Maximilian Krüger; Dennis Strand; Ulrich Förstermann
Journal:  Circulation       Date:  2007-04-02       Impact factor: 29.690

5.  The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

Authors:  S L Primo-Parmo; R C Sorenson; J Teiber; B N La Du
Journal:  Genomics       Date:  1996-05-01       Impact factor: 5.736

6.  Expression of human paraoxonase (PON1) during development.

Authors:  Toby B Cole; Rachel L Jampsa; Betsy J Walter; Tara L Arndt; Rebecca J Richter; Diana M Shih; Aaron Tward; Aldons J Lusis; Rhona M Jack; Lucio G Costa; Clement E Furlong
Journal:  Pharmacogenetics       Date:  2003-06

7.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

Review 8.  Pharmacogenetics of paraoxonases: a brief review.

Authors:  D I Draganov; B N La Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-25       Impact factor: 3.000

Review 9.  Oxidative stress and its significant roles in neurodegenerative diseases and cancer.

Authors:  Raynoo Thanan; Shinji Oikawa; Yusuke Hiraku; Shiho Ohnishi; Ning Ma; Somchai Pinlaor; Puangrat Yongvanit; Shosuke Kawanishi; Mariko Murata
Journal:  Int J Mol Sci       Date:  2014-12-24       Impact factor: 5.923

10.  DJ-1 interacts with and regulates paraoxonase-2, an enzyme critical for neuronal survival in response to oxidative stress.

Authors:  Mohammad Parsanejad; Noam Bourquard; Dianbo Qu; Yi Zhang; En Huang; Maxime W C Rousseaux; Hossein Aleyasin; Isabella Irrcher; Steve Callaghan; Dominique C Vaillant; Raymond H Kim; Ruth S Slack; Tak W Mak; Srinivasa T Reddy; Daniel Figeys; David S Park
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more
  13 in total

1.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

2.  Sex and genetic differences in the effects of acute diesel exhaust exposure on inflammation and oxidative stress in mouse brain.

Authors:  Toby B Cole; Jacki Coburn; Khoi Dao; Pam Roqué; Yu-Chi Chang; Vrinda Kalia; Tomas R Guilarte; Jennifer Dziedzic; Lucio G Costa
Journal:  Toxicology       Date:  2016-11-16       Impact factor: 4.221

3.  Expression of PON2 isoforms varies among brain regions in male and female African green monkeys.

Authors:  Sumit Jamwal; Jennifer K Blackburn; John D Elsworth
Journal:  Free Radic Biol Med       Date:  2021-12-07       Impact factor: 7.376

4.  Pioglitazone transiently stimulates paraoxonase-2 expression in male nonhuman primate brain: Implications for sex-specific therapeutics in neurodegenerative disorders.

Authors:  Jennifer K Blackburn; Sumit Jamwal; Weiwei Wang; John D Elsworth
Journal:  Neurochem Int       Date:  2021-11-09       Impact factor: 3.921

Review 5.  Parkinson's disease treatment: past, present, and future.

Authors:  John D Elsworth
Journal:  J Neural Transm (Vienna)       Date:  2020-03-14       Impact factor: 3.575

6.  Pioglitazone activates paraoxonase-2 in the brain: A novel neuroprotective mechanism.

Authors:  Jennifer K Blackburn; Daniel W Curry; Anna N Thomsen; Robert H Roth; John D Elsworth
Journal:  Exp Neurol       Date:  2020-02-07       Impact factor: 5.330

Review 7.  PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders.

Authors:  Sumit Jamwal; Jennifer K Blackburn; John D Elsworth
Journal:  Pharmacol Ther       Date:  2020-10-09       Impact factor: 12.310

8.  Sex-based disparity in paraoxonase-2 expression in the brains of African green monkeys.

Authors:  Sumit Jamwal; Jennifer K Blackburn; John D Elsworth
Journal:  Free Radic Biol Med       Date:  2021-03-17       Impact factor: 7.376

9.  Paraoxonase 2 deficiency in mice alters motor behavior and causes region-specific transcript changes in the brain.

Authors:  Jacqueline M Garrick; Toby B Cole; Theo K Bammler; James W MacDonald; Judit Marsillach; Clement E Furlong; Lucio G Costa
Journal:  Neurotoxicol Teratol       Date:  2021-07-01       Impact factor: 4.071

Review 10.  Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview.

Authors:  Débora Levy; Cadiele Oliana Reichert; Sérgio Paulo Bydlowski
Journal:  Antioxidants (Basel)       Date:  2019-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.